← All indications
Hypercalcemia
Abnormally high level of calcium in the blood.
Drugs by status
Approved for this indication (11)
Phase 4 trials (3)
Phase 2 trials (4)
Other trials (3)
Organizations
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (12)
- Kyowa Hakko Kirin
- National Cancer Institute (NCI)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Velindre NHS Trust
- Aarhus University
- Albany Medical College
- University of Washington
- Herbert Irving Comprehensive Cancer Center
- Loyola University
- Southwest Oncology Group
- Cardiff University
- Columbia University
Organization Involved with Phase 2 Indications (12)
- Chugai
- Huazhong University of Science and Technology
- University of Pennsylvania
- Case Western Reserve University
- Peking University
- Sun Yat-Sen University
- First People's Hospital Fo Shan City
- People's Hospital Shun De City
- Shantou University
- Shijiazhuang Pharma Group (CSPC)
- People's Hospital of Zhongshan
- Shanghai JMT-Bio Inc.
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (7)